These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 4232015

  • 1. [Treatment of cutaneous leishmaniasis of acutely necrotizing type with solusurmine].
    Dobrzhanskaia RS.
    Vestn Dermatol Venerol; 1966 Oct; 40(10):57-61. PubMed ID: 4232015
    [No Abstract] [Full Text] [Related]

  • 2. [Aminoquinol in the therapy of the acute necrotising form of cutaneous leishmaniasis].
    Ben'iaminov BA.
    Vestn Dermatol Venerol; 1966 Jun; 40(6):75-7. PubMed ID: 5988391
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Chemotherapy of leishmaniasis. Recent studies].
    Magaudda PL, Pennisi L.
    G Ital Chemioter; 1978 Jun; 25(2):97-106. PubMed ID: 755795
    [No Abstract] [Full Text] [Related]

  • 7. American cutaneous leishmaniasis: disappearance of amastigotes from lesions during antimonial therapy.
    Mayrink W, Raso P, Melo MN, Michalick MS, Magalhães PA, Williams P, da Costa CA, Dias M.
    Rev Inst Med Trop Sao Paulo; 1983 Jun; 25(6):265-9. PubMed ID: 6672988
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
    Solomon M, Baum S, Barzilai A, Pavlotsky F, Trau H, Schwartz E.
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Toxicity and efficacy of the antileishmanial drug meglumine antimoniate in the owl monkey (Aotus trivirgatus).
    Chapman WL, Hanson WL, Hendricks LD.
    J Parasitol; 1983 Dec; 69(6):1176-7. PubMed ID: 6674468
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study.
    Santos JB, de Jesus AR, Machado PR, Magalhães A, Salgado K, Carvalho EM, Almeida RP.
    J Infect Dis; 2004 Nov 15; 190(10):1793-6. PubMed ID: 15499535
    [Abstract] [Full Text] [Related]

  • 16. [Vibramycin and levamisole in the treatment of cutaneous leishmaniasis].
    Haddad SM, Kochergin NG.
    Vestn Dermatol Venerol; 1985 Aug 15; (8):43-6. PubMed ID: 3907186
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Search for and development of antileishmaniasis preparations (a review of the literature)].
    Chistiakov DA, Drabkina AA, Rusak LV.
    Med Parazitol (Mosk); 1982 Aug 15; 51(4):57-63. PubMed ID: 6752683
    [No Abstract] [Full Text] [Related]

  • 19. [Cutaneous leishmaniasis in patients returning from the tropics].
    Heimgartner E.
    Schweiz Rundsch Med Prax; 1984 Feb 07; 73(6):165-8. PubMed ID: 6324316
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.